Aurobindo Pharma announces FDA final approval for Amphotericin B Liposome for Injection

Aurobindo Pharma announces FDA final approval for Amphotericin B Liposome for Injection

Aurobindo Pharma said that its fully-owned subsidiary — Eugia Pharma Specialities has secured final approval for Amphotericin B Liposome for Injection, 50 mg from the US Food & Drug Administration (FDA). The approved product is bioequivalent and therapeutically equivalent to Astellas Pharma US’ AmBisome Liposome for Injection, 50 mg/vial. Amphotericin B Liposome for Injection is […]

Cadila Healthcare to bring Black Fungus drug AmphoTLC to India

Cadila Healthcare to bring Black Fungus drug AmphoTLC to India

Cadila Healthcare (also known as Zydus Cadila) has signed a license supply and commercialization agreement with Taiwanese pharma company TLC to commercialize the latter’s Black Fungus drug – AmphoTLC (Amphotericin B Liposome for Injection 50mg) in India. As per the terms of the deal, TLC will manufacture and supply AmphoTLC on a non-exclusive basis to […]